Table 3.
Demographic information on clinical trial #2.
| All subjects | ||||
|---|---|---|---|---|
| N | 130 | |||
| Age (years) | ||||
| Mean | 58.7 ± 8.0 | |||
| Ethnicity | ||||
| Hispanic or Latino | 17 | (13.1) | ||
| Not Hispanic or Latino | 113 | (86.9) | ||
| Race | ||||
| American Indian or Alaska Native | 1 | (0.8) | ||
| Asian | 16 | (12.2) | ||
| Black or African American | 0 | (0.0) | ||
| White | 112 | (86.2) | ||
| Multiracial | 1 | (0.8) | ||
| ITT population | 130 | |||
| Completed subjects (PP population) | 116 | |||
| Discontinued subjects | 14 | |||
| Reason for discontinuation | ||||
| Adverse event | 9 | |||
| Non-compliance | 2 | |||
| Investigator decision | 1 | |||
| Lost to follow-up | 2 | |||
ITT, Intend-to-Treat; PP, Per Protocol.